Mark Foley
Experienced MedTech Executive with 25+ years of experience including roles as a senior executive, CEO (public and private companies), Founder/entrepreneur, Venture Capitalist and Board Member/Executive Chairman/Chairman. Served as Chairman, President and Chief Executive Officer of ZELTIQ Aesthetics (ZLTQ) from April of 2012 until the Company's acquisition by Allergan for $2.5B in April of 2017. Initially, I joined ZELTIQ in 2009 as Executive Chairman and as a member of the Board of Directors. Currently, I am a Managing Director at RWI Ventures, serve as Chairman of the Board for ULab, HintMD and Arrinex and am a board member at Glaukos (GKOS) and Revance (RVNC). Prior to this, I served on the boards of several private companies, held operating roles in large, public companies and venture-backed start-ups including US Surgical Corporation, Guidant Corporation, Devices for Vascular Intervention (acquired by Eli Lilly), Perclose (acquired by Abbott) and Ventrica (acquired by Medtronic) where I was the founder and CEO.
- Company WebsiteVisit Site